![Andrea Pirzkall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrea Pirzkall
No open positions remaining
Profile
Andrea Pirzkall worked as the Chief Medical Director at Genentech, Inc. from 2007 to 2017.
She then worked as the Executive Director-Clinical Development at BeiGene Ltd. from 2017 to 2020.
Prior to that, she was the Director-Clinical Affairs at DxTx Medical, Inc. from 2002 to 2003.
Most recently, she served as the Chief Medical Officer at Replimune Group, Inc. from 2020 to 2021.
Pirzkall earned a doctorate degree from Friedrich Schiller University of Jena.
Former positions of Andrea Pirzkall
| Companies | Position | End |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Tech/Sci/R&D Officer | 2021-08-24 |
| BEIGENE LTD | Chief Tech/Sci/R&D Officer | 2020-06-30 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Chief Tech/Sci/R&D Officer | 2017-07-31 |
DxTx Medical, Inc.
 DxTx Medical, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for MRI imaging and radiation therapy of the prostate | Chief Tech/Sci/R&D Officer | 2002-12-31 |
Training of Andrea Pirzkall
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
82
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Friedrich Schiller University of Jena
 Friedrich Schiller University of Jena Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
BeiGene Ltd.
 BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
DxTx Medical, Inc.
DxTx Medical, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for MRI imaging and radiation therapy of the prostate | Health Technology |
- Stock Market
- Insiders
- Andrea Pirzkall
